General Information of the Compound
| Compound ID |
CP0426962
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
7-(2,5-dimethylpyrazol-3-yl)-3-[2-[[4-methyl-5-(5-methylpyrazin-2-yl)-1,2,4-triazol-3-yl]sulfanyl]ethyl]-1,2,4,5-tetrahydro-3-benzazepine
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C25H30N8S
|
||||||||||||||||||
| Molecular Weight |
474.638
|
||||||||||||||||||
| Canonical SMILES |
Cc1cc(-c2ccc3CCN(CCSc4nnc(-c5cnc(C)cn5)n4C)CCc3c2)n(C)n1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C25H30N8S/c1-17-13-23(32(4)30-17)21-6-5-19-7-9-33(10-8-20(19)14-21)11-12-34-25-29-28-24(31(25)3)22-16-26-18(2)15-27-22/h5-6,13-16H,7-12H2,1-4H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
FJVFFJPYYUVVJU-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01005, D(2) dopamine receptor
Protein ID: PT00943, D(3) dopamine receptor
Protein ID: PT00897, Potassium voltage-gated channel subfamily H member 2